Patent details

EP3201203 Title: CRYSTALLINE FORM OF 1-(1-METHYL-1H-PYRAZOL-4-YL)-N-((1R,5S,7S)-9-METHYL-3-OXA-9-AZABICYCLO[3.3.1]NONAN-7-YL)-1H-INDOLE-3-CARBOXAMIDE

Basic Information

Publication number:
EP3201203
PCT Application Number:
US2015052806
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP157781626
PCT Publication Number:
WO2016053947
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
CRYSTALLINE FORM OF 1-(1-METHYL-1H-PYRAZOL-4-YL)-N-((1R,5S,7S)-9-METHYL-3-OXA-9-AZABICYCLO[3.3.1]NONAN-7-YL)-1H-INDOLE-3-CARBOXAMIDE
French Title of Invention:
FORME CRISTALLINE DE 1-(1-MÉTHYL-1H-PYRAZOL -4-YL)-N- ((1R,5S,7S) -9-MÉTHYL-3-OXA-9-AZABICYCLO[3.3.1]NONAN-7-YL)-1H-INDOLE-3-CARBOXAMIDE
German Title of Invention:
KRISTALLINE FORM VON 1-(1-METHYL-1H-PYRAZOL-4-YL)-N-((1R,5S,7S)-9-METHYL-3-OXA-9-AZABICYCLO[3.3.1]NONAN-7-YL)-1H-INDOL-3-CARBOXAMID
SPC Number:

Dates

Filing date:
29/09/2015
Grant date:
19/05/2021
EP Publication Date:
09/08/2017
PCT Publication Date:
07/04/2016
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
19/05/2021
EP B1 Publication Date:
19/05/2021
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
29/09/2021
Expiration date:
29/09/2035
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
12/05/2021
 
 

Name:
Takeda Pharmaceutical Company Limited
Address:
1-1 Doshomachi 4-chome Chuo-ku, Osaka-shi, Osaka 541-0045, Japan (JP)

Inventor

Name:
ZHAO, Yuxin
Address:
United States (US)

Priority

Priority Number:
201462056982 P
Priority Date:
29/09/2014
Priority Country:
United States (US)

Classification

IPC classification:
C07D 498/08; A61K 31/5386; A61P 1/00; A61P 1/08; A61P 25/06; A61P 25/16; A61P 25/18; A61P 25/22; A61P 25/24; A61P 25/30;

Publication

European Patent Bulletin

Issue number:
202120
Publication date:
19/05/2021
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages